Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/20046414

Yonsei Med. J. 2009 Dec 31 50 6 757-63

Download in:

View as

General Info

PMID
20046414